Segments - China General Surgical Devices Market by Products (Electro Surgical Devices, Handheld Devices, Laparoscopic Devices, Trocars and Access Devices, Wound Closure Devices, and Others), Applications (Orthopaedic, Gynecology & Urology, Neurology, Cardiology, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The China General Surgical Devices Market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 6.1% during 2023–2031. The growth of the market is attributed to the growing population and increasing demand for advanced surgeries.
General surgical devices are used in common surgeries or operations for modifying or removal of affected biological tissue in the body. In order to meet the requirements for critical surgeries, continuous advancements have been done for manufacturing of surgical devices.
Some surgical instruments are designed for general use, while others are designed for a specific medical procedure. Surgical instruments such as cutting & dissecting instruments, grasping or holding instruments, hemostatic instruments, retractors, and tissue unifying instruments are widely used by surgeons, physicians, and medical students.
Patient awareness about the cost benefits of early surgical intervention and rising worldwide healthcare expenditure are key factors that can increase the use and manufacturing of surgical devices. The most common surgeries such as appendectomy, cataract surgery, refractive lens exchange, C-section, and echocardiogram widely utilizes general surgical devices.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems. The outbreak situation resulted into nationwide lockdowns, which disrupted the supply of healthcare facilities and manufacturing of surgical devices. The stringent regulations and slowdown in economy hampered the growth of the surgical market.
Rising demand for reconstructive surgeries is the major factor propelling the market growth during the projected period.
Increasing number of surgical procedures and growing technological advancements are estimated to contribute to the market expansion during the forecast period.
Growing applications of surgical equipments in distinctive surgical techniques is estimated to positively influence the market growth in the coming years.
High cost associated with the surgical treatments is expected to hamper the growth of market during the forecast period.
Growing industrial investments for developing advanced surgery devices and increasing research & development activities for innovative product launches are the factors anticipated to create lucrative opportunities for the market in the coming years.
The report on the China general surgical devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
General Surgical Devices Market - China Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Products (Electro Surgical Devices, Handheld Devices, Laparoscopic Devices, Trocars and Access Devices, Wound Closure Devices, and Others) and Applications (Orthopaedic, Gynecology & Urology, Neurology, Cardiology, and Others) |
Country |
China |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Stryker Corporation; B. Braun Melsungen AG; Johnson & Johnson; Boston Scientific Corporation; and Olympus Corporation |
Based on products, themarket is segregated into electro surgical devices, handheld devices, laparoscopic devices, trocars & access devices, wound closure devices, and others. The handheld devices segment is projected to dominate the market during the forecast period owing to the rising demand for general surgeries such as appendectomy, breast biopsy, hysteroscopy, and low back pain surgery.
Moreover, the increasing demand for advanced surgical devices is anticipated to propel the growth of the market segment in the coming years. On the other hand, the laparoscopic devices segment is anticipated to hold a significant market share during the forecast period due to the rising demand for diagnosis and therapeutic procedures of various diseases such as pancreatic cancer, prostatectomy, and gastrointestinal disorders.
The use of laparoscopic devices in surgical procedures ensures minimal bleeding and supports maintaining hemostasis. Therefore, high preference for laparoscopic devices by surgeons and physicians is expected to fuel the growth of the market segment during the forecast period.
On the basis of applications, the market is segmented into orthopaedic, gynecology & urology, neurology, cardiology, and others. The gynecology & urology segment is anticipated to register at substantial CAGR during the forecast period owing to the increasing prevalence of urinary incontinence, pelvic organ prolapse, and overactive bladder and rising expenditure on medical surgeries.
Furthermore, the increasing number of reconstructive surgeries is estimated to fuel the growth of the market in the coming years. However, the cardiology segment is anticipated to exhibit a substantial growth during the projected period owing to the rising incidences of congenital heart defects, coronary artery disease, heart failure, valve disease, and electrophysiology.
Moreover, the growing consumer disposable income, unhealthy diet, and changing lifestyle are some of the factors to boost the market segment growth in the coming years.
The China general surgical devices market is segmented on the basis of
The key players competing in the China general surgical devices market are Stryker Corporation; B. Braun Melsungen AG; Johnson & Johnson; Boston Scientific Corporation; and Olympus Corporation. Companies are focusing on growing manufacturing facilities, along with forming strong distribution networks with other industry players in order to expand their market shares.
In January 2021, Boston Scientific Corporation announced the reallocation of its cardiac rhythm management and research & development resources. The reallocation aimed to increase productivity, innovation, and competitiveness to enhance the ability to deliver new products to the physicians and patients.